story of the week
Circulating Tumour DNA in Patients With Advanced Melanoma Treated With Dabrafenib or Dabrafenib Plus Trametinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating Tumour DNA in Patients With Advanced Melanoma Treated With Dabrafenib or Dabrafenib Plus Trametinib: A Clinical Validation Study
Lancet Oncol 2021 Feb 12;[EPub Ahead of Print], MM Syeda, JM Wiggins, BC Corless, GV Long, KT Flaherty, D Schadendorf, PD Nathan, C Robert, A Ribas, MA Davies, JJ Grob, E Gasal, M Squires, M Marker, J Garrett, JC Brase, D PolskyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.